Home » Newsletters » BioWorld Science

BioWorld Science

May 23, 2022

View Archived Issues

Deep Visual Proteomics links protein abundance to cellular phenotypes and preserves spatial context

ATH-1019 reduces pain in STZ-induced diabetic neuropathy

RORgammat agonist improves efficacy of anti-PD-1 in a murine lung cancer model

Sichuan Kelun-Biotech Biopharmaceutical patents Raf/Ras kinase inhibitors

Chinese researchers disclose BCL2 mutant inhibitors

Shanghai Meizer Pharmaceuticals identifies new PROTACs for cancer

Immix reports promising survival data with IMX-110 in mouse soft tissue sarcoma study

Shanghai Meizer Pharmaceuticals presents new PTPN11 inhibitors

New PROTACs developed by Luzhou Baicaotang Chinese Traditional Medicine

PASylated-nomacopan explored in preclinical models of ocular disorders

EXG-001-307: a novel gene therapy for spinal muscular atrophy

Novel cofilin inhibitor for the treatment of hemorrhagic brain injury

A novel gene therapy for heart failure treatment based on DWORF micropeptide

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...